Medical Affairs & Social Media | Key Social Media Activities

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical’s Road Map for Social Media Success: Social Media Activities”

STUDY OVERVIEW

Medical Affairs leaders are increasingly recognizing the significance of social media for engaging key stakeholders like thought leaders, health care providers, patients and digital opinion leaders. However, Medical Affairs leaders need to identify the right social media platforms to engage their target audiences with effective activities.

Best Practices, LLC undertook benchmarking research to construct a roadmap for Medical Affairs’ social media success. The study examines key social media activities for effectively educating the market. It delivers benchmarks around the social media platforms utilized, target audiences, social media goals, proactive vs. reactive interaction proportions, and proactive social media activities for medical.

Insights in this study are further segmented by Therapeutic area (Oncology – n=17, Immunology – n=11, and Rare Disease segment – n=8) and Geographic area (Global – n=32, U.S. Only – n=11, and Europe Only – n=5) to provide deeper understanding.

KEY TOPICS

Platforms Used
Target Audiences
Social Media Goals
Proactive vs. Reactive Interaction Proportions
Proactive Social Media Activities for Medical

KEY METRICS

Please indicate the social media platforms which are utilized by Medical Affairs groups
Which groups are target audiences for Medical’s social media activities?
Which goals are priorities for Medical Affairs group’s social media efforts?
What percentage of Medical Affairs’ social media engagements are currently proactive vs. reactive?
Please indicate how effective each social media platform is for each of the listed proactive activities
Please rate the effectiveness of each proactive activity in engaging each target audience

SAMPLE KEY FINDINGS

Channel Agility: Social channels are used for different purposes to reach diverse stakeholders with different content. Clinical trials, new science, government affairs, PAG’s, and corporate scientific branding are innovation fronts.

METHODOLOGY

Best Practices, LLC engaged 48 Medical leaders from 36 biopharma companies in this benchmarking research using an integrated framework to construct the roadmap for social media success under Medical Affairs auspices across 21 therapeutic areas.

Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Manufacturing; Consumer Products; Diagnostic; Communications; Medical; Biopharmaceutical; Health Care; Consulting

Companies Profiled:
AbbVie; Avidity Biosciences; AstraZeneca; Baxter Healthcare; Bayer; BIAL; Boehringer Ingelheim; Boston Scientific; Complete HealthVizion | An IPG Health Company; Domp�; DURECT Corporation; Eisai; Elevation Oncology; EMD Serono; Ethicon Endo-Surgery Inc.; Gossamer Bio; Grifols; Hoya Vision Care; Janssen; LEO Pharma; MedVal Scientific Information Services; Merck KGaA; Merck Sharp & Dohme; Merz Pharma; Merz Aesthetics; Myovant Sciences; Nobel Biocare; Novartis; Novartis Oncology; Novo Nordisk; PRECISIONscientia; Servier; Supernus; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical’s Road Map for Social Media Success: Social Media Activities

ID: 5751

Features:

Pages/Slides: 63

Published: 2023

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
64DC361F4F03369F80025895E003BE31A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medicals-road-map-social-media-success-activities?OpenDocument
18
19OpenDocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB